UK markets open in 1 hour 11 minutes
NIKKEI 225
38,136.45 -92.66 (-0.24%) HANG SENG
19,094.28 +130.60 (+0.69%) CRUDE OIL
77.99 -0.27 (-0.35%) GOLD FUTURES
2,357.90 -17.10 (-0.72%) DOW
39,512.84 +837.14 (+2.16%) Bitcoin GBP
48,641.87 -22.11 (-0.05%)
NeuroOne Medical Technologies Corporation (NMTC)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 29.04M |
| Enterprise value | 26.52M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 7.98 |
| Price/book (mrq) | 6.57 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 1.06 |
| 52-week change 3 | -21.68% |
| S&P500 52-week change 3 | 26.27% |
| 52-week high 3 | 2.0000 |
| 52-week low 3 | 0.8500 |
| 50-day moving average 3 | 1.1738 |
| 200-day moving average 3 | 1.1731 |
Share statistics
| Avg vol (3-month) 3 | 210.38k |
| Avg vol (10-day) 3 | 152.81k |
| Shares outstanding 5 | 25.93M |
| Implied shares outstanding 6 | 26.86M |
| Float 8 | 19.52M |
| % held by insiders 1 | 12.09% |
| % held by institutions 1 | 25.68% |
| Shares short (30 Apr 2024) 4 | 278.64k |
| Short ratio (30 Apr 2024) 4 | 1.73 |
| Short % of float (30 Apr 2024) 4 | 1.12% |
| Short % of shares outstanding (30 Apr 2024) 4 | 1.07% |
| Shares short (prior month 28 Mar 2024) 4 | 365.33k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:3 |
| Last split date 3 | 01 Apr 2021 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Sept 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -346.80% |
Management effectiveness
| Return on assets (ttm) | -109.49% |
| Return on equity (ttm) | -214.01% |
Income statement
| Revenue (ttm) | 2.82M |
| Revenue per share (ttm) | 0.14 |
| Quarterly revenue growth (yoy) | -37.70% |
| Gross profit (ttm) | N/A |
| EBITDA | -13.34M |
| Net income avi to common (ttm) | -13.47M |
| Diluted EPS (ttm) | -0.6800 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 2.68M |
| Total cash per share (mrq) | 0.1 |
| Total debt (mrq) | 153.72k |
| Total debt/equity (mrq) | 3.48% |
| Current ratio (mrq) | 3.68 |
| Book value per share (mrq) | 0.18 |
Cash flow statement
| Operating cash flow (ttm) | -13.2M |
| Levered free cash flow (ttm) | -8.61M |
© 2024 Yahoo. All rights reserved.